PROTHENA CORP PUBLIC LTD COPRTA
| Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | 177 | 294 | 371 | 387 | 418 | 428 | 376 | 295 | 579 | 710 | 619 |
---|
Prepaid expenses and other current assets | 1 | 4 | 6 | 4 | 8 | 4 | 3 | 3 | 6 | 9 | 14 |
---|
Accounts receivable | - | 2 | 1 | 0 | 0 | 0 | - | 0 | - | - | 5 |
---|
Prepaid expenses and other current assets | 1 | 4 | 6 | 4 | 8 | 4 | 3 | 3 | 6 | 9 | 14 |
---|
Restricted cash, current | - | - | - | - | - | - | - | 1 | - | - | 1 |
---|
Total current assets | 178 | 299 | 377 | 391 | 426 | 431 | 378 | 299 | 585 | 719 | 639 |
---|
Property and equipment, net | 3 | 3 | 4 | 56 | 55 | 53 | 4 | 3 | 2 | 2 | 4 |
---|
Operating lease right-of-use assets | - | - | - | - | - | - | 23 | 18 | 12 | 6 | 12 |
---|
Deferred tax assets | - | - | - | - | - | - | - | 12 | 7 | 18 | 34 |
---|
Restricted Cash, Noncurrent | - | - | - | - | - | - | 3 | 1 | 1 | 2 | 1 |
---|
Other non-current assets | - | - | 1 | 2 | 3 | 1 | 1 | 0 | 2 | 11 | 6 |
---|
Total non-current assets | 4 | 5 | 8 | 69 | 70 | 67 | 41 | 34 | 25 | 39 | 57 |
---|
Total assets | 182 | 304 | 385 | 460 | 496 | 499 | 419 | 333 | 609 | 758 | 696 |
---|
Accounts payable | 2 | 5 | 5 | 13 | 14 | 1 | 1 | 4 | 4 | 9 | 25 |
---|
Accrued research and development | 2 | 2 | 13 | 19 | 14 | 5 | 6 | 9 | 6 | 11 | 15 |
---|
Deferred revenue, current | - | - | - | - | - | - | - | - | 8 | 11 | - |
---|
Lease liability, current | - | - | - | - | - | - | 5 | 6 | 6 | 6 | 1 |
---|
Other current liabilities | 4 | 5 | 5 | 9 | 9 | 6 | 6 | 7 | 10 | 12 | 16 |
---|
Total current liabilities | 7 | 12 | 22 | 41 | 37 | 15 | 18 | 26 | 33 | 50 | 57 |
---|
Deferred Revenue, Noncurrent | - | - | - | - | - | 110 | 110 | 110 | 103 | 85 | 67 |
---|
Lease liability, non-current | - | - | - | - | - | - | 18 | 12 | 6 | - | 11 |
---|
Other liabilities | - | - | 0 | - | - | 1 | 1 | 1 | 1 | 1 | - |
---|
Total non-current liabilities | 2 | 2 | 2 | 53 | 52 | 161 | 129 | 123 | 110 | 86 | 78 |
---|
Total liabilities | 9 | 14 | 25 | 95 | 89 | 176 | 146 | 149 | 143 | 136 | 135 |
---|
Deferred Shares Value | - | - | - | - | - | - | - | - | - | - | - |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
---|
Additional paid-in capital | 214 | 338 | 489 | 654 | 849 | 921 | 944 | 967 | 1,182 | 1,455 | 1,541 |
---|
Accumulated deficit | -41 | -48 | -129 | -289 | -442 | -598 | -672 | -783 | -716 | -833 | -980 |
---|
Total shareholders’ equity | 173 | 290 | 361 | 365 | 407 | 323 | 273 | 184 | 466 | 622 | 561 |
---|
Total liabilities and shareholders’ equity | 182 | 304 | 385 | 460 | 496 | 499 | 419 | 333 | 609 | 758 | 696 |
---|